Oaktree Acquisition Corp. III Life Sciences Unit (OACCU) Stock Overview
Explore Oaktree Acquisition Corp. III Life Sciences Unit’s financial performance, market position, analyst ratings, and future outlook.
Oaktree Acquisition Corp. III Life Sciences Unit (OACCU)
Key Financials
Key Financials
Market Cap
259.7M
P/E Ratio
37.66
EPS (TTM)
$0.27
ROE
0.03%
OACCU Stock Analysis & Investment Overview (NASDAQ)
Our AI-powered analysis of Oaktree Acquisition Corp. III Life Sciences Unit (NASDAQ: OACCU) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Oaktree Acquisition Corp. III Life Sciences Unit's NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of OACCU on the NASDAQ shows an RSI of 28.05, suggesting the stock is in a an oversold condition. Our forecasting models predict a 12-month price target of $11.06 for the NASDAQ listing.
Key metrics behind Oaktree Acquisition Corp. III Life Sciences Unit's NASDAQ-traded stock include a P/E ratio of 37.66 and a market capitalization of 259.7M. Combined with our AI analysis, these give both institutional and retail investors a clear view of OACCU on the NASDAQ.